EGFR and chronic kidney disease: Moreover, we show antagonism of the EGFR to prevent the BBB-permeabilizing actions of serum in CKD patients, offering a potential new pathway to protect against uremia-associated cerebrovascular damage linked to the actions of the gut microbiota.